Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT02511301 | Circadian Thermal Sensing to Detect Breast Disease | unknown | Phase 1 / Phase 2 | 173 | Cyrcadia HealthINDUSTRY | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03775928 |
| Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer |
| unknown |
| Phase 2 |
| 80 |
| Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER |
| 1 |
| Dec 14, 2018 |
| clinicaltrials |
| NCT03735082 | Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer | unknown | Phase 2 | 29 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03696004 | Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt | unknown | Phase 2 / Phase 3 | 45 | Assiut UniversityOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT03692689 | Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer | unknown | Phase 2 | 30 | Sinocelltech Ltd.INDUSTRY | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02689921 | NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer(NEOADAPT) | unknown | Phase 2 | 7 | Midwestern Regional Medical CenterOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT03688958 | Iodine Supplementation on Breast Cancer | unknown | Phase 2 | 120 | Universidad Nacional Autonoma de MexicoOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT03684863 | Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy | unknown | Phase 2 | 200 | Shandong Cancer Hospital and InstituteOTHER | 0 | Sep 26, 2018 | clinicaltrials |
| NCT02030678 | A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer | unknown | Phase 2 | 124 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT02596373 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer | unknown | Phase 2 | 60 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03606369 | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. | unknown | Phase 2 / Phase 3 | 560 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT02095743 | Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer(EPIC) | unknown | Phase 2 | 256 | Centre Henri BecquerelOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT02939274 | An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer | unknown | Phase 2 | 15 | Rogers Sciences Inc.INDUSTRY | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02000193 | Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer(FANCY) | unknown | Phase 2 | 58 | Sun Yat-sen UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03175341 | Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | unknown | Phase 1 / Phase 2 | 30 | Academic Emergency County Hospital SibiuOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03566394 | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 46 | British Columbia Cancer AgencyOTHER | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03562390 | Irinotecan for Advanced and Metastatic Breast Cancer | unknown | Phase 2 | 124 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jun 19, 2018 | clinicaltrials |
| NCT03560856 | A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer(PALPETBIO) | unknown | Phase 2 | 54 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Jun 18, 2018 | clinicaltrials |
| NCT03507465 | Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer | unknown | Phase 2 / Phase 3 | 290 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03497702 | Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer(NeoChAI) | unknown | Phase 2 | 114 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | unknown | Phase 2 / Phase 3 | 60 | Centro Hospitalar Lisboa OcidentalOTHER_GOV | 0 | Apr 9, 2018 | clinicaltrials |
| NCT03429972 | Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients | unknown | Phase 2 | 51 | National Cancer Centre, SingaporeOTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT03457467 | Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer | unknown | Phase 2 | 30 | Yan LiOTHER | 0 | Mar 7, 2018 | clinicaltrials |
| NCT03412955 | A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes | unknown | Phase 2 | 14 | Tan Tock Seng HospitalOTHER | 2 | Feb 27, 2018 | clinicaltrials |
| NCT03444025 | Neoadjuvant Goserelin for Triple Negative Breast Cancer(NeoGONT) | unknown | Phase 2 | 180 | Kasr El Aini HospitalOTHER | 0 | Feb 23, 2018 | clinicaltrials |
| NCT02213991 | Intraoperative Radiotherapy for Korean Patients With Breast Cancer | unknown | Phase 2 | 215 | Gangnam Severance HospitalOTHER | 1 | Feb 15, 2018 | clinicaltrials |
| NCT02214004 | Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women(HERAKLES) | unknown | Phase 2 | 132 | Gangnam Severance HospitalOTHER | 1 | Feb 15, 2018 | clinicaltrials |
| NCT03423849 | The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Feb 6, 2018 | clinicaltrials |
| NCT03412383 | Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer | unknown | Phase 2 | 14 | Peking Union Medical CollegeOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT02953184 | Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy | unknown | Phase 2 | 160 | Jilin UniversityOTHER | 1 | Dec 29, 2017 | clinicaltrials |
| NCT02910050 | Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer(BETTER) | unknown | Phase 2 | 58 | Xu feiOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03373708 | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Dec 18, 2017 | clinicaltrials |
| NCT03348098 | Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT03349177 | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03242551 | Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer(BINC-B) | unknown | Phase 2 | 120 | Shenzhen People's HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT02694224 | Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients(SHH-CM) | unknown | Phase 2 | 40 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT02673268 | Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction(MARCI) | unknown | Phase 2 | 80 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT03275727 | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer(INNOVBC) | unknown | Phase 2 / Phase 3 | 128 | Linkoeping UniversityOTHER_GOV | 0 | Sep 8, 2017 | clinicaltrials |
| NCT03273595 | Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer | unknown | Phase 2 | 100 | Xijing HospitalOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT00723294 | Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer | unknown | Phase 2 | 99 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 14, 2017 | clinicaltrials |
| NCT03085368 | A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin | unknown | Phase 2 / Phase 3 | 482 | Peking Union Medical College HospitalOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02489409 | Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer | unknown | Phase 2 | 120 | Xinjiang Medical UniversityOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT03213925 | Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer | unknown | Phase 2 | 1 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT03211572 | The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers(OTT 17-01) | unknown | Phase 2 | 82 | Ottawa Hospital Research InstituteOTHER | 0 | Jul 7, 2017 | clinicaltrials |
| NCT01830244 | IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer(Neonab) | unknown | Phase 2 | 60 | Barwon HealthOTHER_GOV | 1 | Jul 2, 2017 | clinicaltrials |
| NCT03204734 | Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer | unknown | Phase 2 | 132 | Zhejiang Cancer HospitalOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT03202862 | The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 0 | Jun 29, 2017 | clinicaltrials |
| NCT02684318 | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 100 | Poveda, Andrés, M.D.INDIV | 1 | Jun 22, 2017 | clinicaltrials |
| NCT03192293 | Metformin and Simvastatin in Addition to Fulvestrant | unknown | Phase 2 | 28 | National University Hospital, SingaporeOTHER | 1 | Jun 20, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 11, 2019source: clinicaltrials